<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-11-01" modified="2018-01-31" version="212">
<accession>P17948</accession>
<accession>A3E342</accession>
<accession>A3E344</accession>
<accession>A8KA71</accession>
<accession>B0LPF1</accession>
<accession>B2BF46</accession>
<accession>B2BF47</accession>
<accession>B2BF48</accession>
<accession>B3FR89</accession>
<accession>B5A923</accession>
<accession>F5H5L6</accession>
<accession>O60722</accession>
<accession>P16057</accession>
<accession>Q12954</accession>
<name>VGFR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Vascular endothelial growth factor receptor 1</fullName>
<shortName>VEGFR-1</shortName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Fms-like tyrosine kinase 1</fullName>
<shortName>FLT-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase FRT</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase receptor FLT</fullName>
<shortName>FLT</shortName>
</alternativeName>
<alternativeName>
<fullName>Vascular permeability factor receptor</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">FLT1</name>
<name type="synonym">FLT</name>
<name type="synonym">FRT</name>
<name type="synonym">VEGFR1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Oncogene" volume="5" first="519" last="524">
<title>Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.</title>
<authorList>
<person name="Shibuya M."/>
<person name="Yamaguchi S."/>
<person name="Yamane A."/>
<person name="Ikeda T."/>
<person name="Tojo A."/>
<person name="Matsushime H."/>
<person name="Sato M."/>
</authorList>
<dbReference type="PubMed" id="2158038"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="10705" last="10709">
<title>Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.</title>
<authorList>
<person name="Kendall R.L."/>
<person name="Thomas K.A."/>
</authorList>
<dbReference type="PubMed" id="8248162"/>
<dbReference type="DOI" id="10.1073/pnas.90.22.10705"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>PROTEIN SEQUENCE OF N-TERMINUS</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 2)</scope>
<scope>INTERACTION WITH VEGFA</scope>
<scope>FUNCTION</scope>
<source>
<tissue>Umbilical vein</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="262" first="731" last="738">
<title>Characterization of the VEGF binding site on the Flt-1 receptor.</title>
<authorList>
<person name="Herley M.T."/>
<person name="Yu Y."/>
<person name="Whitney R.G."/>
<person name="Sato J.D."/>
</authorList>
<dbReference type="PubMed" id="10471394"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.1282"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH VEGFA</scope>
<scope>GLYCOSYLATION</scope>
<source>
<tissue>Umbilical vein</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2008" name="Arthritis Res. Ther." volume="10" first="R73" last="R73">
<title>Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.</title>
<authorList>
<person name="Jin P."/>
<person name="Zhang J."/>
<person name="Sumariwalla P.F."/>
<person name="Ni I."/>
<person name="Jorgensen B."/>
<person name="Crawford D."/>
<person name="Phillips S."/>
<person name="Feldmann M."/>
<person name="Shepard H.M."/>
<person name="Paleolog E.M."/>
</authorList>
<dbReference type="PubMed" id="18593464"/>
<dbReference type="DOI" id="10.1186/ar2447"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<scope>FUNCTION IN LIGAND BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2008" name="Circ. Res." volume="102" first="1566" last="1574">
<title>A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.</title>
<authorList>
<person name="Sela S."/>
<person name="Itin A."/>
<person name="Natanson-Yaron S."/>
<person name="Greenfield C."/>
<person name="Goldman-Wohl D."/>
<person name="Yagel S."/>
<person name="Keshet E."/>
</authorList>
<dbReference type="PubMed" id="18515749"/>
<dbReference type="DOI" id="10.1161/CIRCRESAHA.108.171504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>ROLE IN PREECLAMPSIA</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2010" name="J. Cell. Biochem." volume="110" first="732" last="742">
<title>A novel intracellular isoform of VEGFR-1 activates Src and promotes cell invasion in MDA-MB-231 breast cancer cells.</title>
<authorList>
<person name="Mezquita B."/>
<person name="Mezquita J."/>
<person name="Pau M."/>
<person name="Mezquita C."/>
</authorList>
<dbReference type="PubMed" id="20512933"/>
<dbReference type="DOI" id="10.1002/jcb.22584"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5; 6; 7 AND 8)</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF SRC AND CANCER CELL INVASIVENESS</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="7">
<citation type="submission" date="2007-12" db="EMBL/GenBank/DDBJ databases">
<title>A new VEGFR1 receptor transcript coding for the extracellular domains of the protein followed by a C-terminal polyserine tail.</title>
<authorList>
<person name="Mezquita J."/>
<person name="Mezquita B."/>
<person name="Pau M."/>
<person name="Mezquita C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="8">
<citation type="submission" date="2007-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3)</scope>
<source>
<tissue>Placenta</tissue>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Nature" volume="428" first="522" last="528">
<title>The DNA sequence and analysis of human chromosome 13.</title>
<authorList>
<person name="Dunham A."/>
<person name="Matthews L.H."/>
<person name="Burton J."/>
<person name="Ashurst J.L."/>
<person name="Howe K.L."/>
<person name="Ashcroft K.J."/>
<person name="Beare D.M."/>
<person name="Burford D.C."/>
<person name="Hunt S.E."/>
<person name="Griffiths-Jones S."/>
<person name="Jones M.C."/>
<person name="Keenan S.J."/>
<person name="Oliver K."/>
<person name="Scott C.E."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews D.T."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Bannerjee R."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burrill W."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M.E."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S.C."/>
<person name="Cobley V."/>
<person name="Collins J.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Deloukas P."/>
<person name="Dhami P."/>
<person name="Dunham I."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.G."/>
<person name="Faulkner L."/>
<person name="Frankish A.G."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gilbert J.G.R."/>
<person name="Gilson C.J."/>
<person name="Ghori J."/>
<person name="Grafham D.V."/>
<person name="Gribble S.M."/>
<person name="Griffiths C."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.J."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Lloyd C."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="McLaren S.J."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K.M."/>
<person name="Rice C.M."/>
<person name="Searle S."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thomas D.W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wright M.W."/>
<person name="Young L."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Beck S."/>
<person name="Bentley D.R."/>
<person name="Rogers J."/>
<person name="Ross M.T."/>
</authorList>
<dbReference type="PubMed" id="15057823"/>
<dbReference type="DOI" id="10.1038/nature02379"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="1987" name="Jpn. J. Cancer Res." volume="78" first="655" last="661">
<title>A possible new member of tyrosine kinase family, human frt sequence, is highly conserved in vertebrates and located on human chromosome 13.</title>
<authorList>
<person name="Matsushime H."/>
<person name="Yoshida M.C."/>
<person name="Sasaki M."/>
<person name="Shibuya M."/>
</authorList>
<dbReference type="PubMed" id="3040650"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1018-1058</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 1)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="23410" last="23418">
<title>Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules.</title>
<authorList>
<person name="Ito N."/>
<person name="Wernstedt C."/>
<person name="Engstrom U."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="9722576"/>
<dbReference type="DOI" id="10.1074/jbc.273.36.23410"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION AT TYR-914; TYR-1213; TYR-1242; TYR-1327 AND TYR-1333</scope>
<scope>MUTAGENESIS OF TYR-914; TYR-1213; TYR-1242; TYR-1327 AND TYR-1333</scope>
<scope>INTERACTION WITH PLCG; GRB2; CRK; NCK1 AND PTPN11</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1995" name="Oncogene" volume="10" first="135" last="147">
<title>A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.</title>
<authorList>
<person name="Seetharam L."/>
<person name="Gotoh N."/>
<person name="Maru Y."/>
<person name="Neufeld G."/>
<person name="Yamaguchi S."/>
<person name="Shibuya M."/>
</authorList>
<dbReference type="PubMed" id="7824266"/>
</citation>
<scope>INTERACTION WITH VEGFA</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF PLCG</scope>
<scope>ABSENCE OF MITOGENIC FUNCTION IN CULTURED FIBROBLASTS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1996" name="Blood" volume="87" first="3336" last="3343">
<title>Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.</title>
<authorList>
<person name="Barleon B."/>
<person name="Sozzani S."/>
<person name="Zhou D."/>
<person name="Weich H.A."/>
<person name="Mantovani A."/>
<person name="Marme D."/>
</authorList>
<dbReference type="PubMed" id="8605350"/>
</citation>
<scope>FUNCTION IN CELL MIGRATION</scope>
<scope>FUNCTION IN VEGFA AND PGF SIGNALING</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1997" name="Biochem. Biophys. Res. Commun." volume="238" first="487" last="491">
<title>The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma.</title>
<authorList>
<person name="Sawano A."/>
<person name="Takahashi T."/>
<person name="Yamaguchi S."/>
<person name="Shibuya M."/>
</authorList>
<dbReference type="PubMed" id="9299537"/>
<dbReference type="DOI" id="10.1006/bbrc.1997.7327"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PLCG AND ACTIVATION OF MAP KINASES</scope>
<scope>INTERACTION WITH PLCG</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF LYS-861 AND TYR-1169</scope>
<scope>PHOSPHORYLATION AT TYR-1169 AND TYR-1213</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="246" first="95" last="99">
<title>Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2.</title>
<authorList>
<person name="Igarashi K."/>
<person name="Isohara T."/>
<person name="Kato T."/>
<person name="Shigeta K."/>
<person name="Yamano T."/>
<person name="Uno I."/>
</authorList>
<dbReference type="PubMed" id="9600074"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.8578"/>
</citation>
<scope>INTERACTION WITH PIK3R1; PTPN11 AND NCK1</scope>
<scope>PHOSPHORYLATION AT TYR-1213</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Am. J. Pathol." volume="158" first="265" last="273">
<title>Vascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cells.</title>
<authorList>
<person name="Dunk C."/>
<person name="Ahmed A."/>
</authorList>
<dbReference type="PubMed" id="11141500"/>
<dbReference type="DOI" id="10.1016/S0002-9440(10)63965-X"/>
</citation>
<scope>FUNCTION AS NEGATIVE REGULATOR OF KDR-MEDIATED CELL PROLIFERATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="Biochem. J." volume="358" first="465" last="472">
<title>Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase binding.</title>
<authorList>
<person name="Yu Y."/>
<person name="Hulmes J.D."/>
<person name="Herley M.T."/>
<person name="Whitney R.G."/>
<person name="Crabb J.W."/>
<person name="Sato J.D."/>
</authorList>
<dbReference type="PubMed" id="11513746"/>
<dbReference type="DOI" id="10.1042/0264-6021:3580465"/>
</citation>
<scope>INTERACTION WITH PIK3R1 AND VEGFA</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT TYR-1213</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="Growth Factors" volume="19" first="193" last="206">
<title>Effect of placenta growth factor-1 on proliferation and release of nitric oxide, cyclic AMP and cyclic GMP in human epithelial cells expressing the FLT-1 receptor.</title>
<authorList>
<person name="Angelucci C."/>
<person name="Lama G."/>
<person name="Iacopino F."/>
<person name="Maglione D."/>
<person name="Sica G."/>
</authorList>
<dbReference type="PubMed" id="11811792"/>
<dbReference type="DOI" id="10.3109/08977190109001086"/>
</citation>
<scope>FUNCTION IN PGF-MEDIATED CHORIOCARCINOMA CELL PROLIFERATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="Int. J. Biochem. Cell Biol." volume="33" first="315" last="324">
<title>Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers.</title>
<authorList>
<person name="Huang K."/>
<person name="Andersson C."/>
<person name="Roomans G.M."/>
<person name="Ito N."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="11312102"/>
<dbReference type="DOI" id="10.1016/S1357-2725(01)00019-X"/>
</citation>
<scope>INTERACTION WITH KDR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>FUNCTION IN VEGFA SIGNALING; PHOSPHORYLATION OF PLCG AND ACTIVATION OF PHOSPHATIDYLINOSITOL KINASE AND PHOSPHOLIPASE C</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Diabetes" volume="52" first="2959" last="2968">
<title>Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.</title>
<authorList>
<person name="Cai J."/>
<person name="Ahmad S."/>
<person name="Jiang W.G."/>
<person name="Huang J."/>
<person name="Kontos C.D."/>
<person name="Boulton M."/>
<person name="Ahmed A."/>
</authorList>
<dbReference type="PubMed" id="14633857"/>
<dbReference type="DOI" id="10.2337/diabetes.52.12.2959"/>
</citation>
<scope>FUNCTION IN SIGNALING VIA ACTIVATION OF THE PHOSPHATIDYLINOSITOL KINASE PATHWAY AND POSITIVE REGULATION OF ANGIOGENESIS IN RESPONSE TO PGF AND VEGFA</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Nat. Med." volume="9" first="936" last="943">
<title>Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.</title>
<authorList>
<person name="Autiero M."/>
<person name="Waltenberger J."/>
<person name="Communi D."/>
<person name="Kranz A."/>
<person name="Moons L."/>
<person name="Lambrechts D."/>
<person name="Kroll J."/>
<person name="Plaisance S."/>
<person name="De Mol M."/>
<person name="Bono F."/>
<person name="Kliche S."/>
<person name="Fellbrich G."/>
<person name="Ballmer-Hofer K."/>
<person name="Maglione D."/>
<person name="Mayr-Beyrle U."/>
<person name="Dewerchin M."/>
<person name="Dombrowski S."/>
<person name="Stanimirovic D."/>
<person name="Van Hummelen P."/>
<person name="Dehio C."/>
<person name="Hicklin D.J."/>
<person name="Persico G."/>
<person name="Herbert J.M."/>
<person name="Communi D."/>
<person name="Shibuya M."/>
<person name="Collen D."/>
<person name="Conway E.M."/>
<person name="Carmeliet P."/>
</authorList>
<dbReference type="PubMed" id="12796773"/>
<dbReference type="DOI" id="10.1038/nm884"/>
</citation>
<scope>INTERACTION WITH PGF AND KDR</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF KDR; VEGFA AND PGF SIGNALING</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>PHOSPHORYLATION AT TYR-1213; TYR-1327 AND TYR-1309</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="FASEB J." volume="18" first="929" last="931">
<title>The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1).</title>
<authorList>
<person name="Kobayashi S."/>
<person name="Sawano A."/>
<person name="Nojima Y."/>
<person name="Shibuya M."/>
<person name="Maru Y."/>
</authorList>
<dbReference type="PubMed" id="15001553"/>
<dbReference type="DOI" id="10.1096/fj.03-0767fje"/>
</citation>
<scope>INTERACTION WITH CBL AND CD2AP</scope>
<scope>UBIQUITINATION</scope>
<scope>AUTOPHOSPHORYLATION IN RESPONSE TO VEGFA</scope>
<scope>MUTAGENESIS OF TYR-1333</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="2647" last="2653">
<title>Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells.</title>
<authorList>
<person name="Fan F."/>
<person name="Wey J.S."/>
<person name="McCarty M.F."/>
<person name="Belcheva A."/>
<person name="Liu W."/>
<person name="Bauer T.W."/>
<person name="Somcio R.J."/>
<person name="Wu Y."/>
<person name="Hooper A."/>
<person name="Hicklin D.J."/>
<person name="Ellis L.M."/>
</authorList>
<dbReference type="PubMed" id="15735759"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208246"/>
</citation>
<scope>FUNCTION IN VEGFA AND VEGFB SIGNALING; CANCER CELL MIGRATION; INVASIVENESS AND ACTIVATION OF MAPK1/ERK2 AND MAPK3/ERK1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Br. J. Cancer" volume="94" first="1710" last="1717">
<title>Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases.</title>
<authorList>
<person name="Lesslie D.P."/>
<person name="Summy J.M."/>
<person name="Parikh N.U."/>
<person name="Fan F."/>
<person name="Trevino J.G."/>
<person name="Sawyer T.K."/>
<person name="Metcalf C.A."/>
<person name="Shakespeare W.C."/>
<person name="Hicklin D.J."/>
<person name="Ellis L.M."/>
<person name="Gallick G.E."/>
</authorList>
<dbReference type="PubMed" id="16685275"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6603143"/>
</citation>
<scope>FUNCTION IN CELL MIGRATION AND PHOSPHORYLATION OF PTK2/FAK1; YES1 AND SRC</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="867" last="875">
<title>A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1.</title>
<authorList>
<person name="Meyer R.D."/>
<person name="Mohammadi M."/>
<person name="Rahimi N."/>
</authorList>
<dbReference type="PubMed" id="16286478"/>
<dbReference type="DOI" id="10.1074/jbc.M506454200"/>
</citation>
<scope>MUTAGENESIS OF ASN-1050</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Arterioscler. Thromb. Vasc. Biol." volume="28" first="322" last="328">
<title>The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes.</title>
<authorList>
<person name="Tchaikovski V."/>
<person name="Fellbrich G."/>
<person name="Waltenberger J."/>
</authorList>
<dbReference type="PubMed" id="18079407"/>
<dbReference type="DOI" id="10.1161/ATVBAHA.107.158022"/>
</citation>
<scope>FUNCTION IN PGF AND VEGFA SIGNALING; PHOSPHORYLATION OF AKT1; MAPK3/ERK1 AND MAP KINASES; CHEMOTAXIS AND ACTIVATION OF PHOSPHATIDYLINOSITOL 3-KINASE</scope>
<scope>AUTOPHOSPHORYLATION IN RESPONSE TO PGF AND VEGFA</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Circ. Res." volume="103" first="261" last="268">
<title>Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.</title>
<authorList>
<person name="Nishi J."/>
<person name="Minamino T."/>
<person name="Miyauchi H."/>
<person name="Nojima A."/>
<person name="Tateno K."/>
<person name="Okada S."/>
<person name="Orimo M."/>
<person name="Moriya J."/>
<person name="Fong G.H."/>
<person name="Sunagawa K."/>
<person name="Shibuya M."/>
<person name="Komuro I."/>
</authorList>
<dbReference type="PubMed" id="18583712"/>
<dbReference type="DOI" id="10.1161/CIRCRESAHA.108.174128"/>
</citation>
<scope>FUNCTION IN ENDOTHELIAL CELL SURVIVAL AND ANGIOGENESIS</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Br. J. Cancer" volume="103" first="82" last="89">
<title>Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement.</title>
<authorList>
<person name="Taylor A.P."/>
<person name="Leon E."/>
<person name="Goldenberg D.M."/>
</authorList>
<dbReference type="PubMed" id="20551949"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6605746"/>
</citation>
<scope>FUNCTION IN CANCER CELL MIGRATION AND ACTIVATION OF MAPK1/ERK2 AND/OR MAPK3/ERK1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="9097" last="9106">
<title>RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3-K/Akt pathway.</title>
<authorList>
<person name="Wang F."/>
<person name="Yamauchi M."/>
<person name="Muramatsu M."/>
<person name="Osawa T."/>
<person name="Tsuchida R."/>
<person name="Shibuya M."/>
</authorList>
<dbReference type="PubMed" id="21212275"/>
<dbReference type="DOI" id="10.1074/jbc.M110.165605"/>
</citation>
<scope>INTERACTION WITH RACK1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="42514" last="42523">
<title>gamma-Secretase and presenilin mediate cleavage and phosphorylation of vascular endothelial growth factor receptor-1.</title>
<authorList>
<person name="Cai J."/>
<person name="Chen Z."/>
<person name="Ruan Q."/>
<person name="Han S."/>
<person name="Liu L."/>
<person name="Qi X."/>
<person name="Boye S.L."/>
<person name="Hauswirth W.W."/>
<person name="Grant M.B."/>
<person name="Boulton M.E."/>
</authorList>
<dbReference type="PubMed" id="22016384"/>
<dbReference type="DOI" id="10.1074/jbc.M111.296590"/>
</citation>
<scope>INTERACTION WITH PSEN1 AND PTPRB</scope>
<scope>DEPHOSPHORYLATION BY PTPRB</scope>
<scope>MUTAGENESIS OF VAL-767</scope>
<scope>PROTEOLYTIC CLEAVAGE BY PSEN1 AT VAL-767</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="Vasc. Cell" volume="3" first="15" last="15">
<title>Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis.</title>
<authorList>
<person name="Ahmad S."/>
<person name="Hewett P.W."/>
<person name="Al-Ani B."/>
<person name="Sissaoui S."/>
<person name="Fujisawa T."/>
<person name="Cudmore M.J."/>
<person name="Ahmed A."/>
</authorList>
<dbReference type="PubMed" id="21752276"/>
<dbReference type="DOI" id="10.1186/2045-824X-3-15"/>
</citation>
<scope>FUNCTION AS DECOY RECEPTORS; REGULATION OF VEGFA SIGNALING AND REGULATION OF KDR ACTIVITY (ISOFORMS 2/3/4)</scope>
<scope>ROLE IN PREECLAMPSIA</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="J. Biochem. Mol. Biol." volume="39" first="469" last="478">
<title>Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.</title>
<authorList>
<person name="Shibuya M."/>
</authorList>
<dbReference type="PubMed" id="17002866"/>
<dbReference type="DOI" id="10.5483/BMBRep.2006.39.5.469"/>
</citation>
<scope>REVIEW ON FUNCTION AS NEGATIVE REGULATOR OF ANGIOGENESIS DURING EMBRYONIC DEVELOPMENT; POSITIVE REGULATION OF MACROPHAGE FUNCTION IN ADULTHOOD; ROLE IN CARCINOGENESIS AND INFLAMMATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="375" first="287" last="291">
<title>VEGF receptor protein-tyrosine kinases: structure and regulation.</title>
<authorList>
<person name="Roskoski R. Jr."/>
</authorList>
<dbReference type="PubMed" id="18680722"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.07.121"/>
</citation>
<scope>REVIEW ON STRUCTURE AND FUNCTION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="Curr. Opin. Cell Biol." volume="21" first="154" last="165">
<title>VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.</title>
<authorList>
<person name="Lohela M."/>
<person name="Bry M."/>
<person name="Tammela T."/>
<person name="Alitalo K."/>
</authorList>
<dbReference type="PubMed" id="19230644"/>
<dbReference type="DOI" id="10.1016/j.ceb.2008.12.012"/>
</citation>
<scope>REVIEW ON ROLE IN ANGIOGENESIS AND CANCER</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2010" name="Biochim. Biophys. Acta" volume="1804" first="567" last="580">
<title>Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling.</title>
<authorList>
<person name="Grunewald F.S."/>
<person name="Prota A.E."/>
<person name="Giese A."/>
<person name="Ballmer-Hofer K."/>
</authorList>
<dbReference type="PubMed" id="19761875"/>
<dbReference type="DOI" id="10.1016/j.bbapap.2009.09.002"/>
</citation>
<scope>REVIEW ON LIGAND SPECIFICITY; FUNCTION; STRUCTURE; PHOSPHORYLATION AND SIGNALING</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="Cancer" volume="116" first="1027" last="1032">
<title>Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1).</title>
<authorList>
<person name="Schwartz J.D."/>
<person name="Rowinsky E.K."/>
<person name="Youssoufian H."/>
<person name="Pytowski B."/>
<person name="Wu Y."/>
</authorList>
<dbReference type="PubMed" id="20127948"/>
<dbReference type="DOI" id="10.1002/cncr.24789"/>
</citation>
<scope>REVIEW ON ROLE IN CANCER</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="Biochem. J." volume="437" first="169" last="183">
<title>Signal transduction by vascular endothelial growth factor receptors.</title>
<authorList>
<person name="Koch S."/>
<person name="Tugues S."/>
<person name="Li X."/>
<person name="Gualandi L."/>
<person name="Claesson-Welsh L."/>
</authorList>
<dbReference type="PubMed" id="21711246"/>
<dbReference type="DOI" id="10.1042/BJ20110301"/>
</citation>
<scope>REVIEW ON LIGAND SPECIFICITY; FUNCTION; STRUCTURE; PHOSPHORYLATION AND SIGNALING</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Proc. Jpn. Acad., B, Phys. Biol. Sci." volume="87" first="167" last="178">
<title>Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia.</title>
<authorList>
<person name="Shibuya M."/>
</authorList>
<dbReference type="PubMed" id="21558755"/>
<dbReference type="DOI" id="10.2183/pjab.87.167"/>
</citation>
<scope>REVIEW ON ROLE IN CANCER AND PREECLAMPSIA</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1997" name="Cell" volume="91" first="695" last="704">
<title>Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.</title>
<authorList>
<person name="Wiesmann C."/>
<person name="Fuh G."/>
<person name="Christinger H.W."/>
<person name="Eigenbrot C."/>
<person name="Wells J.A."/>
<person name="de Vos A.M."/>
</authorList>
<dbReference type="PubMed" id="9393862"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80456-0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 132-226 IN COMPLEX WITH VEGFA</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1999" name="J. Mol. Biol." volume="293" first="531" last="544">
<title>Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.</title>
<authorList>
<person name="Starovasnik M.A."/>
<person name="Christinger H.W."/>
<person name="Wiesmann C."/>
<person name="Champe M.A."/>
<person name="de Vos A.M."/>
<person name="Skelton N.J."/>
</authorList>
<dbReference type="PubMed" id="10543948"/>
<dbReference type="DOI" id="10.1006/jmbi.1999.3134"/>
</citation>
<scope>STRUCTURE BY NMR OF 129-229</scope>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 129-229 IN COMPLEX WITH VEGFA</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH VEGFA</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="10382" last="10388">
<title>The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1.</title>
<authorList>
<person name="Christinger H.W."/>
<person name="Fuh G."/>
<person name="de Vos A.M."/>
<person name="Wiesmann C."/>
</authorList>
<dbReference type="PubMed" id="14684734"/>
<dbReference type="DOI" id="10.1074/jbc.M313237200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 130-229 IN COMPLEX WITH PGF</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="23779" last="23789">
<title>Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity.</title>
<authorList>
<person name="Iyer S."/>
<person name="Darley P.I."/>
<person name="Acharya K.R."/>
</authorList>
<dbReference type="PubMed" id="20501651"/>
<dbReference type="DOI" id="10.1074/jbc.M110.130658"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.71 ANGSTROMS) OF 129-226 IN COMPLEX WITH VEGFB</scope>
<scope>INTERACTION WITH VEGFB</scope>
<scope>SUBUNIT</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] THR-60; LYS-144; GLN-281; ILE-422; GLN-781; VAL-938; ALA-982 AND VAL-1061</scope>
</reference>
<comment type="function">
<text evidence="14 15 17 18 19 22 24 26 27 28 29 31 32 34 36 37 38 39">Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. May play an essential role as a negative regulator of embryonic angiogenesis by inhibiting excessive proliferation of endothelial cells. Can promote endothelial cell proliferation, survival and angiogenesis in adulthood. Its function in promoting cell proliferation seems to be cell-type specific. Promotes PGF-mediated proliferation of endothelial cells, proliferation of some types of cancer cells, but does not promote proliferation of normal fibroblasts (in vitro). Has very high affinity for VEGFA and relatively low protein kinase activity; may function as a negative regulator of VEGFA signaling by limiting the amount of free VEGFA and preventing its binding to KDR. Likewise, isoforms lacking a transmembrane domain, such as isoform 2, isoform 3 and isoform 4, may function as decoy receptors for VEGFA. Modulates KDR signaling by forming heterodimers with KDR. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate and the activation of protein kinase C. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leading to activation of phosphatidylinositol kinase and the downstream signaling pathway. Mediates activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Phosphorylates SRC and YES1, and may also phosphorylate CBL. Isoform 1 phosphorylates PLCG. Promotes phosphorylation of AKT1 at 'Ser-473'. Promotes phosphorylation of PTK2/FAK1. Isoform 7 has a truncated kinase domain; it increases phosphorylation of SRC at 'Tyr-418' by unknown means and promotes tumor cell invasion.</text>
</comment>
<comment type="catalytic activity">
<text evidence="11 15 18 36 39 42">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text>Present in an inactive conformation in the absence of bound ligand. Binding of VEGFA, VEGFB or PGF leads to dimerization and activation by autophosphorylation on tyrosine residues.</text>
</comment>
<comment type="subunit">
<text evidence="12 13 15 16 18 20 21 30 33 35 36 37 39 40 41 42">Interacts with VEGFA, VEGFB and PGF. Monomer in the absence of bound VEGFA, VEGFB or PGF. Homodimer in the presence of bound VEGFA, VEGFB and PGF. Can also form a heterodimer with KDR. Interacts (when tyrosine phosphorylated) with CBL, CRK, GRB2, NCK1, PIK3R1, PLCG, PSEN1 and PTPN11. Probably interacts also with PTPRB. Interacts with RACK1. Identified in a complex with CBL and CD2AP.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-518228">
<id>P22681</id>
<label>CBL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-346340">
<id>P08631</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6530464"/>
<interactant intactId="EBI-6896607">
<id>P98160</id>
<label>HSPG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-1037633">
<id>P49763</id>
<label>PGF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-297779">
<id>Q06124</id>
<label>PTPN11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-2264500">
<id>Q12913</id>
<label>PTPRJ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-1026643">
<id>P15692</id>
<label>VEGFA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1026718"/>
<interactant intactId="EBI-1026691">
<id>P15692-4</id>
<label>VEGFA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Endosome</location>
</subcellularLocation>
<text>Autophosphorylation promotes ubiquitination and endocytosis.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="37">Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 4</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 5</molecule>
<subcellularLocation>
<location evidence="50">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 6</molecule>
<subcellularLocation>
<location evidence="50">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 7</molecule>
<subcellularLocation>
<location evidence="50">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P17948-1</id>
<name>1</name>
<name>Flt1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P17948-2</id>
<name>2</name>
<name>sFlt1</name>
<sequence type="described" ref="VSP_002955 VSP_002956"/>
</isoform>
<isoform>
<id>P17948-3</id>
<name>3</name>
<name>sFlt1-14</name>
<sequence type="described" ref="VSP_041927 VSP_041928"/>
</isoform>
<isoform>
<id>P17948-4</id>
<name>4</name>
<sequence type="described" ref="VSP_041929 VSP_041930"/>
</isoform>
<isoform>
<id>P17948-5</id>
<name>5</name>
<name>i15</name>
<sequence type="described" ref="VSP_041985"/>
</isoform>
<isoform>
<id>P17948-6</id>
<name>6</name>
<name>i18</name>
<sequence type="described" ref="VSP_041984"/>
</isoform>
<isoform>
<id>P17948-7</id>
<name>7</name>
<name>i21</name>
<sequence type="described" ref="VSP_041983"/>
</isoform>
<isoform>
<id>P17948-8</id>
<name>8</name>
<sequence type="described" ref="VSP_047759 VSP_047760"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text evidence="27 31">Detected in normal lung, but also in placenta, liver, kidney, heart and brain tissues. Specifically expressed in most of the vascular endothelial cells, and also expressed in peripheral blood monocytes. Isoform 2 is strongly expressed in placenta. Isoform 3 is expressed in corneal epithelial cells (at protein level). Isoform 3 is expressed in vascular smooth muscle cells (VSMC).</text>
</comment>
<comment type="induction">
<text evidence="27 38">Up-regulated in coculture of VSMC/endothelial cell (EC) or by direct exposure to VEGF of VSMC monoculture. Up-regulated from the second trimester of pregnancy to the term and in the placenta of women with preeclampsia (PE). Up-regulated in monocytes exposed to bacterial lipopolysaccharide (LPS).</text>
</comment>
<comment type="domain">
<text evidence="30 40">The second and third Ig-like C2-type (immunoglobulin-like) domains are sufficient for VEGFA binding.</text>
</comment>
<comment type="PTM">
<text evidence="12 16">N-glycosylated.</text>
</comment>
<comment type="PTM">
<text evidence="21">Ubiquitinated after VEGFA-mediated autophosphorylation, leading to proteolytic degradation.</text>
</comment>
<comment type="PTM">
<text evidence="16 18 39 41 42">Autophosphorylated on tyrosine residues upon ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation at Tyr-1169 is important for interaction with PLCG. Phosphorylation at Tyr-1213 is important for interaction with PIK3R1, PTPN11, GRB2, and PLCG. Phosphorylation at Tyr-1333 is important for endocytosis and for interaction with CBL, NCK1 and CRK. Is probably dephosphorylated by PTPRB.</text>
</comment>
<comment type="disease">
<text>Can contribute to cancer cell survival, proliferation, migration, and invasion, and tumor angiogenesis and metastasis. May contribute to cancer pathogenesis by promoting inflammatory responses and recruitment of tumor-infiltrating macrophages.</text>
</comment>
<comment type="disease">
<text>Abnormally high expression of soluble isoforms (isoform 2, isoform 3 or isoform 4) may be a cause of preeclampsia.</text>
</comment>
<comment type="similarity">
<text evidence="10">Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="X51602">
<property type="protein sequence ID" value="CAA35946.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U01134">
<property type="protein sequence ID" value="AAC50060.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF063657">
<property type="protein sequence ID" value="AAC16449.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU826561">
<property type="protein sequence ID" value="ACF47597.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU368830">
<property type="protein sequence ID" value="ACA62948.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ836394">
<property type="protein sequence ID" value="ABI53803.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ836395">
<property type="protein sequence ID" value="ABI53804.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ836396">
<property type="protein sequence ID" value="ABI53805.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF491868">
<property type="protein sequence ID" value="ABS32268.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF491869">
<property type="protein sequence ID" value="ABS32269.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF491870">
<property type="protein sequence ID" value="ABS32270.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU360600">
<property type="protein sequence ID" value="ACB05747.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU332841">
<property type="protein sequence ID" value="ABY87530.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292936">
<property type="protein sequence ID" value="BAF85625.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300392">
<property type="protein sequence ID" value="BAG62125.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL138712">
<property type="protein sequence ID" value="CAI14846.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL139005">
<property type="protein sequence ID" value="CAI14846.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL139005">
<property type="protein sequence ID" value="CAI17096.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL138712">
<property type="protein sequence ID" value="CAI17096.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471075">
<property type="protein sequence ID" value="EAX08431.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471075">
<property type="protein sequence ID" value="EAX08432.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC039007">
<property type="protein sequence ID" value="AAH39007.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D00133">
<property type="protein sequence ID" value="BAA00080.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53860.1">
<molecule id="P17948-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53861.1">
<molecule id="P17948-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS73556.1">
<molecule id="P17948-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9330.1">
<molecule id="P17948-1"/>
</dbReference>
<dbReference type="PIR" id="A49636">
<property type="entry name" value="A49636"/>
</dbReference>
<dbReference type="PIR" id="S09982">
<property type="entry name" value="S09982"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001153392.1">
<molecule id="P17948-2"/>
<property type="nucleotide sequence ID" value="NM_001159920.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001153502.1">
<molecule id="P17948-3"/>
<property type="nucleotide sequence ID" value="NM_001160030.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001153503.1">
<molecule id="P17948-4"/>
<property type="nucleotide sequence ID" value="NM_001160031.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002010.2">
<molecule id="P17948-1"/>
<property type="nucleotide sequence ID" value="NM_002019.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.594454"/>
<dbReference type="PDB" id="1FLT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="X/Y=132-226"/>
</dbReference>
<dbReference type="PDB" id="1QSV">
<property type="method" value="NMR"/>
<property type="chains" value="A=129-229"/>
</dbReference>
<dbReference type="PDB" id="1QSZ">
<property type="method" value="NMR"/>
<property type="chains" value="A=129-229"/>
</dbReference>
<dbReference type="PDB" id="1QTY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="T/U/X/Y=129-229"/>
</dbReference>
<dbReference type="PDB" id="1RV6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="X/Y=130-229"/>
</dbReference>
<dbReference type="PDB" id="2XAC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="C/X=129-226"/>
</dbReference>
<dbReference type="PDB" id="3HNG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=801-1158"/>
</dbReference>
<dbReference type="PDB" id="4CKV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.06"/>
<property type="chains" value="X=132-225"/>
</dbReference>
<dbReference type="PDB" id="4CL7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D=132-225"/>
</dbReference>
<dbReference type="PDB" id="5ABD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="E/I/X=132-226"/>
</dbReference>
<dbReference type="PDB" id="5EX3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.41"/>
<property type="chains" value="D=827-835"/>
</dbReference>
<dbReference type="PDB" id="5T89">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="X/Y=27-656"/>
</dbReference>
<dbReference type="PDBsum" id="1FLT"/>
<dbReference type="PDBsum" id="1QSV"/>
<dbReference type="PDBsum" id="1QSZ"/>
<dbReference type="PDBsum" id="1QTY"/>
<dbReference type="PDBsum" id="1RV6"/>
<dbReference type="PDBsum" id="2XAC"/>
<dbReference type="PDBsum" id="3HNG"/>
<dbReference type="PDBsum" id="4CKV"/>
<dbReference type="PDBsum" id="4CL7"/>
<dbReference type="PDBsum" id="5ABD"/>
<dbReference type="PDBsum" id="5EX3"/>
<dbReference type="PDBsum" id="5T89"/>
<dbReference type="ProteinModelPortal" id="P17948"/>
<dbReference type="SMR" id="P17948"/>
<dbReference type="BioGrid" id="108609">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="DIP" id="DIP-643N"/>
<dbReference type="IntAct" id="P17948">
<property type="interactions" value="30"/>
</dbReference>
<dbReference type="MINT" id="MINT-127610"/>
<dbReference type="STRING" id="9606.ENSP00000282397"/>
<dbReference type="BindingDB" id="P17948"/>
<dbReference type="ChEMBL" id="CHEMBL1868"/>
<dbReference type="DrugBank" id="DB06080">
<property type="generic name" value="ABT-869"/>
</dbReference>
<dbReference type="DrugBank" id="DB06626">
<property type="generic name" value="Axitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB06101">
<property type="generic name" value="IMC-1C11"/>
</dbReference>
<dbReference type="DrugBank" id="DB09078">
<property type="generic name" value="Lenvatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB07288">
<property type="generic name" value="N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB09079">
<property type="generic name" value="Nintedanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05913">
<property type="generic name" value="OSI-930"/>
</dbReference>
<dbReference type="DrugBank" id="DB06589">
<property type="generic name" value="Pazopanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00398">
<property type="generic name" value="Sorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01268">
<property type="generic name" value="Sunitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05075">
<property type="generic name" value="TG100801"/>
</dbReference>
<dbReference type="DrugBank" id="DB04879">
<property type="generic name" value="Vatalanib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1812"/>
<dbReference type="iPTMnet" id="P17948"/>
<dbReference type="PhosphoSitePlus" id="P17948"/>
<dbReference type="UniCarbKB" id="P17948"/>
<dbReference type="BioMuta" id="FLT1"/>
<dbReference type="DMDM" id="143811474"/>
<dbReference type="EPD" id="P17948"/>
<dbReference type="MaxQB" id="P17948"/>
<dbReference type="PaxDb" id="P17948"/>
<dbReference type="PeptideAtlas" id="P17948"/>
<dbReference type="PRIDE" id="P17948"/>
<dbReference type="DNASU" id="2321"/>
<dbReference type="Ensembl" id="ENST00000282397">
<molecule id="P17948-1"/>
<property type="protein sequence ID" value="ENSP00000282397"/>
<property type="gene ID" value="ENSG00000102755"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000539099">
<molecule id="P17948-4"/>
<property type="protein sequence ID" value="ENSP00000442630"/>
<property type="gene ID" value="ENSG00000102755"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000541932">
<molecule id="P17948-3"/>
<property type="protein sequence ID" value="ENSP00000437631"/>
<property type="gene ID" value="ENSG00000102755"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000543394">
<molecule id="P17948-8"/>
<property type="protein sequence ID" value="ENSP00000437841"/>
<property type="gene ID" value="ENSG00000102755"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000615840">
<molecule id="P17948-2"/>
<property type="protein sequence ID" value="ENSP00000484039"/>
<property type="gene ID" value="ENSG00000102755"/>
</dbReference>
<dbReference type="GeneID" id="2321"/>
<dbReference type="KEGG" id="hsa:2321"/>
<dbReference type="UCSC" id="uc001usb.4">
<molecule id="P17948-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2321"/>
<dbReference type="DisGeNET" id="2321"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000102755.10"/>
<dbReference type="GeneCards" id="FLT1"/>
<dbReference type="H-InvDB" id="HIX0130593"/>
<dbReference type="HGNC" id="HGNC:3763">
<property type="gene designation" value="FLT1"/>
</dbReference>
<dbReference type="HPA" id="CAB068189"/>
<dbReference type="HPA" id="CAB068190"/>
<dbReference type="HPA" id="HPA011740"/>
<dbReference type="HPA" id="HPA014290"/>
<dbReference type="MIM" id="165070">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P17948"/>
<dbReference type="OpenTargets" id="ENSG00000102755"/>
<dbReference type="PharmGKB" id="PA28180"/>
<dbReference type="eggNOG" id="KOG0200">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118923"/>
<dbReference type="HOGENOM" id="HOG000037949"/>
<dbReference type="HOVERGEN" id="HBG053432"/>
<dbReference type="InParanoid" id="P17948"/>
<dbReference type="KO" id="K05096"/>
<dbReference type="OMA" id="CTCVAAT"/>
<dbReference type="OrthoDB" id="EOG091G01TL"/>
<dbReference type="PhylomeDB" id="P17948"/>
<dbReference type="TreeFam" id="TF325768"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-194306">
<property type="pathway name" value="Neurophilin interactions with VEGF and VEGFR"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-195399">
<property type="pathway name" value="VEGF binds to VEGFR leading to receptor dimerization"/>
</dbReference>
<dbReference type="SignaLink" id="P17948"/>
<dbReference type="SIGNOR" id="P17948"/>
<dbReference type="ChiTaRS" id="FLT1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P17948"/>
<dbReference type="GeneWiki" id="FLT1"/>
<dbReference type="GenomeRNAi" id="2321"/>
<dbReference type="PRO" id="PR:P17948"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 13"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000102755"/>
<dbReference type="CleanEx" id="HS_FLT1"/>
<dbReference type="ExpressionAtlas" id="P17948">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P17948">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0015629">
<property type="term" value="C:actin cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019838">
<property type="term" value="F:growth factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036332">
<property type="term" value="F:placental growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005021">
<property type="term" value="F:vascular endothelial growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036326">
<property type="term" value="F:VEGF-A-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036327">
<property type="term" value="F:VEGF-B-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0048514">
<property type="term" value="P:blood vessel morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035924">
<property type="term" value="P:cellular response to vascular endothelial growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048598">
<property type="term" value="P:embryonic morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002548">
<property type="term" value="P:monocyte chemotaxis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010863">
<property type="term" value="P:positive regulation of phospholipase C activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030949">
<property type="term" value="P:positive regulation of vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0048010">
<property type="term" value="P:vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036323">
<property type="term" value="P:vascular endothelial growth factor receptor-1 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="8"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR013098">
<property type="entry name" value="Ig_I-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013106">
<property type="entry name" value="Ig_V-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001824">
<property type="entry name" value="Tyr_kinase_rcpt_3_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR009135">
<property type="entry name" value="VEGFR1_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF07679">
<property type="entry name" value="I-set"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01833">
<property type="entry name" value="VEGFRECEPTR1"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SMART" id="SM00406">
<property type="entry name" value="IGv"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="8"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00240">
<property type="entry name" value="RECEPTOR_TYR_KIN_III"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0145">Chemotaxis</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="37">
<location>
<begin position="1"/>
<end position="26"/>
</location>
</feature>
<feature type="chain" description="Vascular endothelial growth factor receptor 1" id="PRO_0000016768">
<location>
<begin position="27"/>
<end position="1338"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="8">
<location>
<begin position="27"/>
<end position="758"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="8">
<location>
<begin position="759"/>
<end position="780"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="8">
<location>
<begin position="781"/>
<end position="1338"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="32"/>
<end position="123"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="151"/>
<end position="214"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="230"/>
<end position="327"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 4">
<location>
<begin position="335"/>
<end position="421"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 5">
<location>
<begin position="428"/>
<end position="553"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 6">
<location>
<begin position="556"/>
<end position="654"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 7">
<location>
<begin position="661"/>
<end position="747"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="10">
<location>
<begin position="827"/>
<end position="1158"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="10">
<location>
<begin position="833"/>
<end position="841"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="10 11">
<location>
<position position="1022"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="10">
<location>
<position position="861"/>
</location>
</feature>
<feature type="site" description="Cleavage; by PSEN1" evidence="50">
<location>
<begin position="767"/>
<end position="768"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="51">
<location>
<position position="914"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="7">
<location>
<position position="1053"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="39">
<location>
<position position="1169"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="16 18 39 41 42">
<location>
<position position="1213"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="42">
<location>
<position position="1242"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="18">
<location>
<position position="1309"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="18 42">
<location>
<position position="1327"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="42">
<location>
<position position="1333"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="100"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="164"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="196"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="251"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="323"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="402"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="417"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="474"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="547"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="597"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="620"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="625"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="666"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="53"/>
<end position="107"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="158"/>
<end position="207"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="252"/>
<end position="311"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="454"/>
<end position="535"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="577"/>
<end position="636"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="682"/>
<end position="731"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_041983" evidence="47">
<location>
<begin position="1"/>
<end position="995"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_041984" evidence="47">
<location>
<begin position="1"/>
<end position="875"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_041985" evidence="47">
<location>
<begin position="1"/>
<end position="782"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8." id="VSP_047759" evidence="47">
<original>MVSYWDT</original>
<variation>MNSDLLV</variation>
<location>
<begin position="1"/>
<end position="7"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8." id="VSP_047760" evidence="47">
<location>
<begin position="8"/>
<end position="984"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_041929" evidence="46">
<original>MASTLVVADSRISGIYICIASNKV</original>
<variation>LPPANSSFMLPPTSFSSNYFHFLP</variation>
<location>
<begin position="518"/>
<end position="541"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_041930" evidence="46">
<location>
<begin position="542"/>
<end position="1338"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002955" evidence="43 44 48">
<original>DQEAPYLLRNLSDHTVAISSSTTLDCHANGV</original>
<variation>GEHCNKKAVFSRISKFKSTRNDCTTQSNVKH</variation>
<location>
<begin position="657"/>
<end position="687"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002956" evidence="43 44 48">
<location>
<begin position="688"/>
<end position="1338"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041927" evidence="43 45 49">
<original>GIILGPGSSTLFIERVTEEDEGVYHCKA</original>
<variation>ELYTSTSPSSSSSSPLSSSSSSSSSSSS</variation>
<location>
<begin position="706"/>
<end position="733"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041928" evidence="43 45 49">
<location>
<begin position="734"/>
<end position="1338"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56409818." id="VAR_042045" evidence="25">
<original>K</original>
<variation>T</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35073261." id="VAR_049719">
<original>I</original>
<variation>L</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55974987." id="VAR_042046" evidence="25">
<original>E</original>
<variation>K</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55687105." id="VAR_042047" evidence="25">
<original>R</original>
<variation>Q</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma sample; somatic mutation." id="VAR_042048" evidence="25">
<original>L</original>
<variation>I</variation>
<location>
<position position="422"/>
</location>
</feature>
<feature type="sequence variant" description="In a glioma low grade oligodendroglioma sample; somatic mutation; dbSNP:rs553261958." id="VAR_042049" evidence="25">
<original>R</original>
<variation>Q</variation>
<location>
<position position="781"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35549791." id="VAR_042050" evidence="25">
<original>M</original>
<variation>V</variation>
<location>
<position position="938"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35832528." id="VAR_042051" evidence="25">
<original>E</original>
<variation>A</variation>
<location>
<position position="982"/>
</location>
</feature>
<feature type="sequence variant" description="In a bladder transitional cell carcinoma sample; somatic mutation." id="VAR_042052" evidence="25">
<original>L</original>
<variation>V</variation>
<location>
<position position="1061"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes proteolytic cleavage by PSEN1." evidence="35">
<original>V</original>
<variation>A</variation>
<location>
<position position="767"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzyme activity. Abolishes interaction with PLCG." evidence="39">
<original>K</original>
<variation>M</variation>
<location>
<position position="861"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces phosphorylation at other tyrosine residues." evidence="42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="914"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly increases kinase activity. Increases activity in promoting proliferation of endothelial cells." evidence="23">
<original>N</original>
<variation>D</variation>
<location>
<position position="1050"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation site. Abolishes interaction with PLCG." evidence="39">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1169"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation site. Abolishes interaction with PIK3R1." evidence="42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1213"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation site." evidence="42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1242"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation site." evidence="42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1327"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation site. Abolishes interaction with CBL." evidence="21 42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1333"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC16449." ref="3" evidence="50">
<original>F</original>
<variation>S</variation>
<location>
<position position="490"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA35946." ref="1" evidence="50">
<original>F</original>
<variation>L</variation>
<location>
<position position="779"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; ABI53803/ABI53804." ref="6" evidence="50">
<original>L</original>
<variation>F</variation>
<location>
<position position="1029"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="140"/>
<end position="142"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="144"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="150"/>
<end position="152"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="160"/>
<end position="162"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="168"/>
<end position="171"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="172"/>
<end position="174"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="181"/>
<end position="187"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="191"/>
<end position="196"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="199"/>
<end position="201"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="203"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="214"/>
<end position="224"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="806"/>
<end position="809"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="817"/>
<end position="820"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="824"/>
<end position="826"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="827"/>
<end position="835"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="837"/>
<end position="848"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="849"/>
<end position="851"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="854"/>
<end position="863"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="869"/>
<end position="883"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="894"/>
<end position="898"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="906"/>
<end position="910"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="917"/>
<end position="922"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="996"/>
<end position="1014"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="1015"/>
<end position="1017"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1025"/>
<end position="1027"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1028"/>
<end position="1030"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1032"/>
<end position="1034"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1036"/>
<end position="1038"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1042"/>
<end position="1044"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="1047"/>
<end position="1049"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1053"/>
<end position="1055"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1063"/>
<end position="1065"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1068"/>
<end position="1073"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1078"/>
<end position="1093"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1107"/>
<end position="1113"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="1114"/>
<end position="1116"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1127"/>
<end position="1136"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1141"/>
<end position="1143"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1147"/>
<end position="1157"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FLT"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QSV"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QSZ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HNG"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4CL7"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5ABD"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10471394"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10543948"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11141500"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11312102"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11513746"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11811792"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12796773"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14633857"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14684734"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15001553"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15735759"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16286478"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16685275"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18079407"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18515749"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18583712"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18593464"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20501651"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20512933"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20551949"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21212275"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21752276"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22016384"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7824266"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8248162"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8605350"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9299537"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9393862"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9600074"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9722576"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18515749"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18593464"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20512933"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8248162"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="50" type="ECO:0000305"/>
<evidence key="51" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="9722576"/>
</source>
</evidence>
<sequence length="1338" mass="150769" checksum="FF3381EEFAF0787C" modified="2007-04-03" version="2" precursor="true">
MVSYWDTGVLLCALLSCLLLTGSSSGSKLKDPELSLKGTQHIMQAGQTLHLQCRGEAAHK
WSLPEMVSKESERLSITKSACGRNGKQFCSTLTLNTAQANHTGFYSCKYLAVPTSKKKET
ESAIYIFISDTGRPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPD
GKRIIWDSRKGFIISNATYKEIGLLTCEATVNGHLYKTNYLTHRQTNTIIDVQISTPRPV
KLLRGHTLVLNCTATTPLNTRVQMTWSYPDEKNKRASVRRRIDQSNSHANIFYSVLTIDK
MQNKDKGLYTCRVRSGPSFKSVNTSVHIYDKAFITVKHRKQQVLETVAGKRSYRLSMKVK
AFPSPEVVWLKDGLPATEKSARYLTRGYSLIIKDVTEEDAGNYTILLSIKQSNVFKNLTA
TLIVNVKPQIYEKAVSSFPDPALYPLGSRQILTCTAYGIPQPTIKWFWHPCNHNHSEARC
DFCSNNEESFILDADSNMGNRIESITQRMAIIEGKNKMASTLVVADSRISGIYICIASNK
VGTVGRNISFYITDVPNGFHVNLEKMPTEGEDLKLSCTVNKFLYRDVTWILLRTVNNRTM
HYSISKQKMAITKEHSITLNLTIMNVSLQDSGTYACRARNVYTGEEILQKKEITIRDQEA
PYLLRNLSDHTVAISSSTTLDCHANGVPEPQITWFKNNHKIQQEPGIILGPGSSTLFIER
VTEEDEGVYHCKATNQKGSVESSAYLTVQGTSDKSNLELITLTCTCVAATLFWLLLTLFI
RKMKRSSSEIKTDYLSIIMDPDEVPLDEQCERLPYDASKWEFARERLKLGKSLGRGAFGK
VVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVVNLLGACTK
QGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKKEKMEPGLEQGKKPRLDSV
TSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSRKCIH
RDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKS
DVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRD
PKERPRFAELVEKLGDLLQANVQQDGKDYIPINAILTGNSGFTYSTPAFSEDFFKESISA
PKFNSGSSDDVRYVNAFKFMSLERIKTFEELLPNATSMFDDYQGDSSTLLASPMLKRFTW
TDSKPKASLKIDLRVTSKSKESGLSDVSRPSFCHSSCGHVSEGKRRFTYDHAELERKIAC
CSPPPDYNSVVLYSTPPI
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>